Roche Chairman Franz B. Humer announces that he will not stand for re-election in 2014
5 March 2013 | By Roche
Roche to inform about plans for succession in autumn 2013...
List view / Grid view
5 March 2013 | By Roche
Roche to inform about plans for succession in autumn 2013...
5 March 2013 | By Roche
Roche announced that the EMA has approved PERJETA (pertuzumab) for patients with previously untreated HER2-positive metastatic breast cancer (mBC)...
4 March 2013 | By Pfizer
Pfizer presented the results from a Phase 3 study...
4 March 2013 | By Boehringer Ingelheim
Interim study results from STARTversoTM 4...
4 March 2013 | By Biogen Idec
“We are encouraged by the FDA’s acceptance of our application..."
4 March 2013 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced the following organizational changes taking place from April 1, 2013...
3 March 2013 | By University of Mississippi
A baby born with the virus that causes AIDS appears to have been cured, scientists announced Sunday...
2 March 2013 | By Sanofi
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that pooled data from two Phase 1b trials with dupilumab (REGN668/SAR231893), an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting the alpha subunit of the interleukin 4 receptor (IL-4R alpha), were presented at the 71st Annual Meeting…
1 March 2013 | By Novartis
Novartis announced that the European Commission has approved llaris (canakinumab, ACZ885)...
1 March 2013 | By Edelman (On behalf of PerkinElmer)
Revolutionaries for Global Health Summit, 5 -6 March 2013, Brussels...
28 February 2013 | By Merck
Merck announces that the Pro Bono Institute (PBI) has selected Executive Vice President Bruce Kuhlik as the winner...
28 February 2013 | By
Agreement brings the number of voluntary...
28 February 2013 | By Boehringer Ingelheim
Boehringer Ingelheim invests in rare diseases...
28 February 2013 | By Novartis
Novartis today announced that it has launched an effort to eliminate rheumatic heart disease in Zambia in collaboration with the Lusaka...
27 February 2013 | By Weber Shandwick
EURORDIS announced that Celgene Corporation has been awarded the prestigious EURORDIS Company Award for excellence in the field of rare diseases...